Endoscopic biliary self-expandable metallic stent in malignant biliary obstruction with or without sphincterotomy: systematic review and meta-analysis

Abstract

Background and aim To assess the rate of adverse events and the technical success rate of biliary stenting with or without EBS. 

Methods A literature search up to February 2017 was performed. Studies assessing adverse events (AEs) and technical success rates of stenting with or without EBS were considered.

Results Seven studies (870 patients; 12 treatment arms) were included. Early AEs, i. e. those occurring within 30 days, were significantly lower in no-EBS vs. EBS-group (11 % vs. 20.1 %; OR: 0.36, 95 %CI: 0.13 – 1.00). Rates of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis were not significantly different in the two groups (no-EBS vs. EBS: 6.1 % vs 5 %; OR: 1.33, 95 %CI: 0.68 – 2.59). The rate of bleeding was significantly lower in patients without EBS (no-EBS vs EBS: 0 % vs 5 %; OR: 0.12, 95 % CI: 0.03 – 0.45). Rates of cholangitis were significantly lower in patients without EBS (no-EBS vs. EBS: 3.3 % vs. 7.4 %; OR: 0.38, 95 %CI: 0.17 – 0.83). Both late AEs and mortality rates did not significantly differ between no-EBS and EBS patients (19.9 % vs. 18.9 %; OR: 0.93, 95 %CI: 0.56 – 1.53, and 2.5 % vs. 2.9 %; OR: 1.18, 95 %CI: 0.22 – 6.29, respectively). The technical success rate for stent insertion also did not differ (98 % vs. 97.6 %; OR: 1.05, 95 %CI: 0.42 – 2.63).

Conclusion EBS seems to be associated, in the first 30 days after the procedure, with an increased risk of cholangitis and bleeding. No difference was observed in the rate of post-ERCP pancreatitis.

• References

• 1 Castells A, Kroser J, Rustgi AK. Gastrointestinal neoplasms. In: Beers MH, Berkow R. , eds. The Merck manual of geriatrics. 3rd. ed. Whitehouse Station, NJ: Merck; 2000: 1134-1153
• 2 Tuqan W, Innabi A, Alawneh A. et al. Prediction of survival following percutaneous biliary drainage for malignant biliary obstruction. J Transl Int Med 2017; 30: 127-131
• 3 Mangiavillano B, Pagano N, Baron TH. et al. Outcome of stenting in biliary and pancreatic benign and malignant diseases: A comprehensive review. World J Gastroenterol 2015; 21: 9038-9054
• 4 Mangiavillano B, Pagano N, Baron TH. et al. Biliary and pancreatic stenting: Devices and insertion techniques in therapeutic endoscopic retrograde cholangiopancreatography and endoscopic ultrasonography. World J Gastrointest Endosc 2016; 8: 143-56
• 5 Kawakubo K, Isayama H, Nakai Y. et al. Risk factors for pancreatitis following transpapillary self-expandable metal stent placement. Surg Endosc 2012; 26: 771-776
• 6 Sofi AA, Nawras A, Alaradi OH. et al. Does endoscopic sphincterotomy reduce the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis after biliary stenting? A systematic review and meta-analysis. Dig Endosc 2016; 28: 394-404
• 7 Cui PJ, Yao J, Zhao YJ. et al. Biliary stenting with or without sphincterotomy for malignant biliary obstruction: a meta-analysis. World J Gastroenterol 2014; 20: 14033-14039
• 8 Di Giorgio P, De Luca L. Comparison of treatment outcomes between biliary plastic stent placement with and without endoscopic sphincterotomy for inoperable malignant common bile duct obstruction. World J Gastroenterol 2004; 10: 1212-1214
• 9 Well GA, Shea B, O’Connell J. et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of non randomized studies in meta-analysis. Available at: http://www.ohri.ca/programs/clinical_epidemiology/ oxford.asp Accessed: 12 August 2016
• 10 Cotton PB, Garrow DA, Gallagher J. et al. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc 2009; 70: 80-88
• 11 Der Simonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188
• 12 Tarnasky PR, Cunningham JT, Hawes RH. et al. Transpapillary stenting of proximal biliary strictures: does biliary sphincterotomy reduce the risk of postprocedure pancreatitis?. Gastrointest Endosc 1997; 45: 46-51
• 13 Simmons DT, Petersen BT, Gostout CJ. et al. Risk of pancreatitis following endoscopically placed large-bore plastic biliary stents with and without biliary sphincterotomy for management of postoperative bile leaks. Surg Endosc 2008; 22: 1459-1463
• 14 Ang TL, Kwek AB, Lim KB. et al. An analysis of the efficacy and safety of a strategy of early precut for biliary access during difficult endoscopic retrograde cholangiopancreatography in a general hospital. J Dig Dis 2010; 11: 306-312
• 15 Simmons DT, Petersen BT, Gostout CJ. et al. Risk of pancreatitis following endoscopically placed large-bore plastic biliary stents with and without biliary sphincterotomy for management of postoperative bile leaks. Surg Endosc 2008; 22: 1459-1463
• 16 Zhou H, Li L, Zhu F. et al. Endoscopic sphincterotomy associated cholangitis in patients receiving proximal biliary self-expanding metal stents. Hepatobiliary Pancreat Dis Int 2012; 11: 643-649
• 17 Nakahara K, Okuse C, Suetani K. et al. Covered metal stenting for malignant lower biliary stricture with pancreatic duct obstruction: is endoscopic sphincterotomy needed?. Gastroenterol Res Pract 2013; 2013: 375613
• 18 Banerjee N, Hilden K, Baron TH. et al. Endoscopic biliary sphincterotomy is not required for transpapillary SEMS placement for biliary obstruction. Dig Dis Sci 2011; 56: 591-595
• 19 Shimizu S, Naitoh I, Nakazawa T. et al. Predictive factors for pancreatitis and cholecystitis in endoscopic covered metal stenting for distal malignant biliary obstruction. J Gastroenterol Hepatol 2013; 28: 68-72
• 20 Artifon EL, Sakai P, Ishioka S. et al. Endoscopic sphincterotomy before deployment of covered metal stent is associated with greater complication rate: a prospective randomized control trial. J Clin Gastroenterol 2008; 42: 815-819
• 21 Hayashi T, Kawakami H, Osanai M. et al. No benefit of endoscopic sphincterotomy before biliary placement of self-expandable metal stents for unresectable pancreatic cancer. Clin Gastroenterol Hepatol 2015; 13: 1151-8.e2